Targeting IGF2 to reprogram the tumor microenvironment for enhanced viro-immunotherapyMin Hye Noh, Ji Young Yoo, Jin Muk Kang et al.|Neuro-Oncology|2024Cited by 22
Education and electronic medical records and genomics network, challenges, and lessons learned from a large-scale clinical trial using polygenic risk scoresJohn J. Connolly, Maya Sabatello, C B NELSON et al.|Genetics in Medicine|2023Cited by 15
Simultaneous Targeting of Tumor Cells and Tumor-Associated Macrophages To Reprogram Glioblastoma Using Trypsinized Extracellular Vesicles Carrying Tumor Suppressive MicroRNAGrace Nguyen, Tae Jin Lee, Min Hye Noh et al.|Nano Letters|2025Cited by 8
DDDR-44. Inducing Senolysis by Tumor Suppressive microRNA to Enhance Oncolytic Virus Efficacy for GlioblastomaJiyeon Kim, Tae Jin Lee, Minxin Huang et al.|Neuro-Oncology|2025Cited by 0
Overcoming IGF1R-Mediated Resistance to Oncolytic HSV1 and Radiotherapy via Triple Combination TherapyJi Young Yoo, Jiyeon Kim, Alexandra Miller et al.|Research Square|2025Cited by 0